Menu Back to Advertising-and-Promotion-Regulatory-and-Affairs-Meeting


Celebrating 30 years of excellence, DIA’s Advertising and Promotions Regulatory Affairs Conference will continue to offer a comprehensive agenda covering the latest updates in the ad promo regulatory space. Industry experts will share best practices for ad promo launch strategies, discuss global ad promo review considerations, and evaluate how clinical trial design impacts promotional practice. Hear from pioneers in the industry on the latest OPDP draft guidance and initiatives, enforcement actions, social science research, and electronic Common Technical Document (eCTD) submission process.
The conference delivers an overview of the current and future state of advertising and promotion, featuring perspectives from medical marketing agencies, regulatory, medical and legal professionals. Whether you are new to the field or have years of experience, you can't afford to miss this opportunity to prepare yourself for what’s coming!

Program Update! FDA publishes 2 final guidances that provide greater clarity about their thinking and recommendations for certain medical product communications. Register to learn how these are being incorporated into the 2019 program.

Who should attend?

Professionals in pharmaceutical, biologics, and medical device companies involved in:

  • Regulatory Affairs
  • Marketing
  • Communications
  • Compliance
  • Medical Information and Affairs
  • Legal
  • Senior Management

Program Committee

  • Micheline  Awad, MBA
    Micheline Awad, MBA Director Regulatory Affairs, Advertising and Promotion
    Neurocrine Biosciences, Inc., United States
  • Glenn N. Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Oncology Promotional Regulatory Affairs
    AstraZeneca, United States
  • Dale  Cooke, MA
    Dale Cooke, MA President
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos VP, NA General Medicines/US Advertising and Promotion, Global Regulatory Affairs
    Sanofi, United States
  • Sheetal  Patel, PharmD
    Sheetal Patel, PharmD Head, Regulatory Advertising and Promotion
    Johnson & Johnson International, United States
  • Michele  Sharp, PharmD
    Michele Sharp, PharmD Senior Director, Global Regulatory Affairs
    Eli Lilly and Company, United States
  • Thomas W. Abrams, MBA
    Thomas W. Abrams, MBA Director, Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare
    APCO Worldwide Inc., United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, LLC, United States
Load More

Contact us

Customer Service


On-Demand Complimantary Webinar

Navigating the Still Murky Waters of Manufacturer Communications: Promotion, Commercial Speech, and Scientific Exchange

Call for Professional Showcase

Guidelines | Submit
Deadline: December 14

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions